2020 ASCO Virtual Direct™ Highlights
Playback speed
10 seconds
2020 ASCO Update on Pancreatic Cancer: Perioperative Chemotherapy + mFOLFIRINOX vs. Gemcitabine/nab-Paclitaxel - Which Option Provides More Benefit for Resectable Pancreatic Ductal Adenocarcinoma?
By
2020 ASCO Virtual Direct™ Highlights
FEATURING
Daniel Lin
By
2020 ASCO Virtual Direct™ Highlights
FEATURING
Daniel Lin
0 views
August 13, 2020
Comments 0
Login to view comments.
Click here to Login
GI